Youzhi Zhu
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Pyrotinib Combined With Trastuzumab and Chemotherapy Neoadjuvant Therapy for HER2-positive Breast Cancer (NCT06035679) | Youzhi Zhu | 2023-08-17 |
Track Youzhi Zhu automatically
Every clearance here is in the API, with alerts when new ones post.